Compile Data Set for Download or QSAR
Report error Found 20 Enz. Inhib. hit(s) with all data for entry = 8008
TargetIntegrin alpha-IIb/beta-3(Human)
Piramal Imaging

US Patent
LigandChemical structure of BindingDB Monomer ID 228637BDBM228637(US9345793, 18 | US9744252, Example 18)
Affinity DataIC50: 3nMT: 2°CAssay Description:The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2017
Entry Details
US Patent

TargetIntegrin alpha-IIb/beta-3(Human)
Piramal Imaging

US Patent
LigandChemical structure of BindingDB Monomer ID 228638BDBM228638(US9345793, 19 | US9744252, Example 19)
Affinity DataIC50: 3nMT: 2°CAssay Description:The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2017
Entry Details
US Patent

TargetIntegrin alpha-IIb/beta-3(Human)
Piramal Imaging

US Patent
LigandChemical structure of BindingDB Monomer ID 228634BDBM228634(US9345793, 15 | US9744252, Example 15)
Affinity DataIC50: 5nMT: 2°CAssay Description:The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2017
Entry Details
US Patent

TargetIntegrin alpha-IIb/beta-3(Human)
Piramal Imaging

US Patent
LigandChemical structure of BindingDB Monomer ID 228635BDBM228635(US9345793, 16 | US9744252, Example 16)
Affinity DataIC50: 6nMT: 2°CAssay Description:The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2017
Entry Details
US Patent

TargetIntegrin alpha-IIb/beta-3(Human)
Piramal Imaging

US Patent
LigandChemical structure of BindingDB Monomer ID 228632BDBM228632(US9345793, 13 | US9744252, Example 13)
Affinity DataIC50: 7nMT: 2°CAssay Description:The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2017
Entry Details
US Patent

TargetIntegrin alpha-IIb/beta-3(Human)
Piramal Imaging

US Patent
LigandChemical structure of BindingDB Monomer ID 228639BDBM228639(US9345793, 20 | US9744252, Example 20)
Affinity DataIC50: 7nMT: 2°CAssay Description:The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2017
Entry Details
US Patent

TargetIntegrin alpha-IIb/beta-3(Human)
Piramal Imaging

US Patent
LigandChemical structure of BindingDB Monomer ID 228631BDBM228631(US9345793, 12 | US9744252, Example 12)
Affinity DataIC50: 8nMT: 2°CAssay Description:The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2017
Entry Details
US Patent

TargetIntegrin alpha-IIb/beta-3(Human)
Piramal Imaging

US Patent
LigandChemical structure of BindingDB Monomer ID 228626BDBM228626(US9345793, 7 | US9744252, Example 7)
Affinity DataIC50: 11nMT: 2°CAssay Description:The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2017
Entry Details
US Patent

TargetIntegrin alpha-IIb/beta-3(Human)
Piramal Imaging

US Patent
LigandChemical structure of BindingDB Monomer ID 228630BDBM228630(US9345793, 11 | US9744252, Example 11)
Affinity DataIC50: 14nMT: 2°CAssay Description:The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2017
Entry Details
US Patent

TargetIntegrin alpha-IIb/beta-3(Human)
Piramal Imaging

US Patent
LigandChemical structure of BindingDB Monomer ID 228627BDBM228627(US9345793, 8 | US9744252, Example 8)
Affinity DataIC50: 14nMT: 2°CAssay Description:The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2017
Entry Details
US Patent

TargetIntegrin alpha-IIb/beta-3(Human)
Piramal Imaging

US Patent
LigandChemical structure of BindingDB Monomer ID 228633BDBM228633(US9345793, 14 | US9744252, Example 14)
Affinity DataIC50: 15nMT: 2°CAssay Description:The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2017
Entry Details
US Patent

TargetIntegrin alpha-IIb/beta-3(Human)
Piramal Imaging

US Patent
LigandChemical structure of BindingDB Monomer ID 228629BDBM228629(US9345793, 10 | US9744252, Example 10)
Affinity DataIC50: 15nMT: 2°CAssay Description:The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2017
Entry Details
US Patent

TargetIntegrin alpha-IIb/beta-3(Human)
Piramal Imaging

US Patent
LigandChemical structure of BindingDB Monomer ID 228625BDBM228625(US9345793, 6 | US9744252, Example 6)
Affinity DataIC50: 16nMT: 2°CAssay Description:The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2017
Entry Details
US Patent

TargetIntegrin alpha-IIb/beta-3(Human)
Piramal Imaging

US Patent
LigandChemical structure of BindingDB Monomer ID 228624BDBM228624(US9345793, 5 | US9744252, Example 5)
Affinity DataIC50: 16nMT: 2°CAssay Description:The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2017
Entry Details
US Patent

TargetIntegrin alpha-IIb/beta-3(Human)
Piramal Imaging

US Patent
LigandChemical structure of BindingDB Monomer ID 228622BDBM228622(US9345793, 3 | US9744252, Example 3)
Affinity DataIC50: 20nMT: 2°CAssay Description:The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2017
Entry Details
US Patent

TargetIntegrin alpha-IIb/beta-3(Human)
Piramal Imaging

US Patent
LigandChemical structure of BindingDB Monomer ID 228628BDBM228628(US9345793, 9 | US9744252, Example 9)
Affinity DataIC50: 21nMT: 2°CAssay Description:The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2017
Entry Details
US Patent

TargetIntegrin alpha-IIb/beta-3(Human)
Piramal Imaging

US Patent
LigandChemical structure of BindingDB Monomer ID 228621BDBM228621(US9345793, 2 | US9744252, Example 2)
Affinity DataIC50: 29nMT: 2°CAssay Description:The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2017
Entry Details
US Patent

TargetIntegrin alpha-IIb/beta-3(Human)
Piramal Imaging

US Patent
LigandChemical structure of BindingDB Monomer ID 228636BDBM228636(US9345793, 17 | US9744252, Example 17)
Affinity DataIC50: 35nMT: 2°CAssay Description:The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2017
Entry Details
US Patent

TargetIntegrin alpha-IIb/beta-3(Human)
Piramal Imaging

US Patent
LigandChemical structure of BindingDB Monomer ID 228623BDBM228623(US9345793, 4 | US9744252, Example 4)
Affinity DataIC50: 84nMT: 2°CAssay Description:The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2017
Entry Details
US Patent

TargetIntegrin alpha-IIb/beta-3(Human)
Piramal Imaging

US Patent
LigandChemical structure of BindingDB Monomer ID 228620BDBM228620(US9345793, 1 | US9744252, Example 1)
Affinity DataIC50: 101nMT: 2°CAssay Description:The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2017
Entry Details
US Patent